Global Antimicrobial Susceptibility Testing Market Size, Forecasts, And Opportunities
Learn about the global antimicrobial susceptibility testing market through The Business Research Company, which provides information on antimicrobial susceptibility testing market size, antimicrobial susceptibility testing market drivers and restraints, antimicrobial susceptibility testing market players, the COVID-19 impact on the antimicrobial susceptibility testing market, and more.
Our annual holiday sale is here! Get your discounted market research reports today.
The antimicrobial susceptibility testing market is expected to grow from $3.01 billion in 2020 to $3.44 billion in 2021 at a compound annual growth rate (CAGR) of 14.2%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global antimicrobial susceptibility testing market is expected to reach $4.33 billion in 2025 at a CAGR of 5.9%.
The rising incidence of infectious diseases is expected to drive innovation in antimicrobial susceptibility testing manufacturing, thus driving the market during the forecast period.
Request A Sample For The Global Antimicrobial Susceptibility Testing Market Report:
The antimicrobial susceptibility testing market consists of sales of antimicrobial susceptibility testing by entities (organizations, sole traders and partnerships) that are engaged in laboratory services that provide antimicrobial susceptibility testing. Antimicrobial susceptibility testing (AST) is a laboratory procedure done by clinical laboratory professionals to identify which antimicrobial specimen is specifically effective for individual patients.
Global antimicrobial susceptibility testing market segments include:
By Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Others
By Products: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
By Application: Diagnostics, Drug Discovery And Development, Epidemiology, Others
By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the antimicrobial susceptibility testing market in 2020.
Rapid antimicrobial susceptibility testing is increasingly being used to avoid misuse of antibiotics and to provide effective treatment and this is emerging as a key trend in the antimicrobial susceptibility testing market. There are many ways to perform antimicrobial susceptibility testing in minutes or few hours. FISH (Fluorescence in situ hybridization) is mostly used in rapid antimicrobial susceptibility testing. The PNA-FISH applies peptide nucleic acid probes that allow rapid and specific binding, this process is applied in QuickFish technology (OpGen) it performs identification of microbial by targeting 16s RNA.
TBRC’s antimicrobial susceptibility testing market report covers:
Major Market Players: BioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Accelerate Diagnostics, Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, BD, Alifax Holding S.p.A., Synbiosis, Zhuhai DL Biotech Co, Mast Group, ELITechGroup, Genefluidics, Mast Group, CONDALAB, and QuantaMatrix.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
The Antimicrobial Susceptibility Testing Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides antimicrobial susceptibility testing market overviews, analyzes and forecasts market size, share, antimicrobial susceptibility testing market players, antimicrobial susceptibility testing market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s antimicrobial susceptibility testing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here is a list of similar reports from The Business Research Company:
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: https://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model